Biology Reference
In-Depth Information
Rowland-Jones SL, Dong T, et al. 1998b. Cytotoxic T cell responses to multiple conserved HIV
epitopes in HIV-resistant prostitutes in Nairobi [see comments]. J Clin Invest 102: 1758±1765.
Schirmbeck R, Deml L, et al. 1995. Priming of class I-restricted cytotoxic T lymphocytes by vacci-
nation with recombinant protein antigens. Vaccine 13: 857±865.
Segal DM, Snider DP. 1989. Targeting and activation of cytotoxic lymphocytes. Chem Immunol 47:
179±213.
Shankar P, Xu Z, et al. 1999. Viral-speci®c cytotoxic T lymphocytes lyse human immunode®ciency
virus-infected primary T lymphocytes by the granule exocytosis pathway. Blood 94: 3084±3093.
Sharma V, Knobloch TJ, et al. 1995. Di¨erential expression of cytokine genes in HIV-1 tat trans-
fected T and B cell lines. Biochem Biophys Res Commun 208: 704±713.
Soudeyns H, Pantaleo G. 1997. New mechanisms of viral persistence in primary human im-
munode®ciency virus (HIV) infection. J Biol Regul Homeost Agents 11: 37±39.
Soudeyns H, Campi G, et al. 2000. Initiation of antiretroviral therapy during primary HIV-1 in-
fection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the
level of T-cell oligoclonality. Blood 95: 1743±1751.
Spaeny-Dekking EH, Hanna WL, et al. 1998. Extracellular granzymes A and B in humans: detec-
tion of native species during CTL responses in vitro and in vivo. J Immunol 160: 3610±3616.
Twigg HL, Soliman DM, et al. 1999. Lymphocytic alveolitis, bronchoalveolar lavage viral load,
and outcome in human immunode®ciency virus infection. Am J Respir Crit Care Med 159:
1439±1444.
Valdez H, Lederman MM. 1997. Cytokines and cytokine therapies in HIV infection. AIDS Clin
Rev: 187±228.
Vikingsson A, Pederson K, et al. 1994. Enumeration of IFN-gamma producing lymphocytes by
¯ow cytometry and correlation with quantitative measurement of IFN-gamma. J Immunol
Methods 173: 219±228.
Walker BD, Plata F. 1990. Cytotoxic T lymphocytes against HIV. AIDS 4: 177±184.
Wilson JD, Ogg GS, et al. 2000. Direct visualization of HIV-1-speci®c cytotoxic T lymphocytes
during primary infection. AIDS 14: 225±233.
Wodarz D, Krakauer DC. 2000. De®ning CTL-induced pathology: implications for HIV. Virology
274: 94±104.
Wodarz D, Klenerman P, et al. 1998. Dynamics of cytotoxic T-lymphocyte exhaustion. Proc R Soc
Lond B Biol Sci 265: 191±203.
Woodberry T, Gardner J, et al. 1999. Immunogenicity of a human immunode®ciency virus (HIV)
polytope vaccine containing multiple HLA A2 HIV CD8() cytotoxic T-cell epitopes. J Virol
73: 5320±5325.
Yamamura Y, Rodriguez N, et al. 1995. Anti-CD4 cytotoxic T lymphocyte (CTL) activity in HIV
patients: ¯ow cytometric analysis. Cell Mol Biol (Noisy-le-grand) 41(Suppl 1): S133±S144.
Zarling AL, Johnson JG, et al. 1999. Induction of primary human CD8
T lymphocyte responses in
vitro using dendritic cells. J Immunol 162: 5197±5204.
Zerhouni B, Sanhadji K, et al. 1997. Loss of T-cell cytotoxic responses in the course of HIV-1 in-
fection. Thymus 24: 203±219.
